S06 I61 G93 G62 G30 G20 G21 G82 G72
Conditions
Interventions
Group 1: Observation Group 1: Persona A: neurological patients
Questionnaire to asses the functional status
-Testung if you can get up in the Alreh device
-EMG-, bodypressure-, kinematics analysis in
Sponsors
Schön Klinik Bad Aibling Harthausen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Persona A: • neurological patients who have been hospitalized at the Schön Klinik Bad Aibling, for example with the following diagnosis: traumatic brain injury, stroke (ischemic or hemorrhagic) or hypoxic brain damage, critical illness polyneuropathy (CIP) and myopathy (CIM), Alzheimer's, Parkinson's, paraplegia • Participate in the daily therapy group "balance in the free seat" or "standin training" or meet the inclusion criteria for such a group: o MFAS point 11: 0 o BBS: Tasks 1, 4 and 6:> 2 points o Help from the assistant during the transfer, aids used in everyday life such as rollator / walking stick o Attention load duration:> 30min with short breaks 1-2min o Got speech understanding • male or female • Probable inpatient stay of at least two weeks from the beginning of the study intervention • Inability to walk (FAC <2) • Device-specific: Weight: <120kg and body size: 150-190 cm Persona B: • Patients with dementia who are admitted to the Alzheimer Center of the Schön Klinik Bad Aibling (ATZ) for a three-week therapy • MMSE =18 • male or female • Device specific: weight <120kg and height: 150-190 cm Persona C: • members • Age = 65 years • male or female • Device specific: weight <120kg and height: 150-190 cm • no motor restrictions
Exclusion criteria
Exclusion criteria: Exclusive criteria for "free-seat balance" group and "stand-up" training (pain when shifting weight / sitting trunk, getting up, standing or sitting down, acute / painful shoulder-hand syndrome) • Severe contractures, severe spasticity (MAS 1> 3) • pronounced neglect • Unstable cardiac arrhythmia • continuous oxygen demand • Uncontrolled other medical problems (cardiovascular disease, severe rheumatoid arthritis, arthritic joint deformities, acute cancers, kidney disease, any form of pulmonary or cardiovascular disease in the final stage, untreated epilepsy). • Heavy florid alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study is to examine the suitability and feasability of the activLife therapy device as a transfer aid from the seat to the stand and from the standing to the seat. Especially the examination of the motor and cognitive conditions for a successful application of patients with neurological diseases is of high relevance. This information is needed in order to establish clear indications for a home application or independent therapy. The review of the primary study goals is based on an exploratory data analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| As a secondary study objective, intervention effects are evaluated in an application observation. It is important to find out what differences exist during the sit-stand-sit transfer in activLife compared to getting up and sitting down with or without other aids (rollator or 4-point stick). The muscle activity in the thigh, the weight load on both legs and the kinematics during the transfer are observed. | — |
Countries
Germany
Contacts
Public ContactFriedemann Müller
Schoen Klinik Bad Aibling
Outcome results
None listed